Low Releasing Mitomycin C Molecule Encapsulated with Chitosan Nanoparticles for Intravesical Installation - Journal of Biomaterials and Nanobiotechnology

JBNB > Vol.8 No.4, October 2017

Journal of Biomaterials and Nanobiotechnology

Volume 8, Issue 4 (October 2017)

ISSN Print: 2158-7027 ISSN Online: 2158-7043

Google-based Impact Factor: 1.69 Citations

Low Releasing Mitomycin C Molecule Encapsulated with Chitosan Nanoparticles for Intravesical Installation ()

HTML XML

Download as PDF (Size: 1089KB) PP. 203-219

DOI: 10.4236/jbnb.2017.84014 1,511 Downloads 3,291 Views Citations

Author(s)

Doğa Kavaz^1,2*, Feyza Kirac³, Mustafa Kirac⁴, Ashok Vaseashta^5,6

Affiliation(s)

¹Bioengineering Department, Cyprus International University, Nicosia, Northern Cyprus.
²Biotechnology Research Center, Cyprus International University, Nicosia, Northern Cyprus.
³Department of Chemistry, Hacettepe University, Ankara, Turkey.
⁴Department of Urology, Koru Ankara Hospital, Ankara, Turkey.
⁵International Clean Water Institute, Manassas, VA, USA.
⁶Office of Research, NJCU—A State University of New Jersey, Jersey City, NJ, USA.

ABSTRACT

The aim of this investigation is preparation of Mitomycin-C encapsulated with chitosan nanoparticles synthesis using ionic gelation technique for intravesical controlled drug delivery systems. This study was conducted in vitro. Cumulative amount of drug released from the nanoparticles was calculated. Mitomycin-C release studies were examined for different pH values. During the drug loading and release studies, initial amount of drug was changed (i.e., 0.5, 1.25 and 2.5 mg) to get different release profiles and the release studies were repeated (n = 6). The loading efficiencies of Mitomycin-C with three different initial concentrations 0.5mg/ml, 1.25 mg/ml and 2.5 mg/ml into chitosan nanoparticles were 54.5%, 47.1% and 36.4%, respectively. For different pH values, the cumulative releases of Mitomycin-C from chitosan nanoparticles were 47% and 53% for pH 6.0 and 7.4, respectively (p < 0.01). For different drug doses, the cumulative releases of Mitomycin-C (MMC) from Chitosan nanoparticles were 44%, 53% and 65% for 0.5 mg/mL, 1.25 mg/mL and 2.5 mg/mL respectively (p < 0.01). The anticancer activity of Mitomycin-C loaded chitosan nanoparticles was measured in T24 bladder cancer cell line in vitro, and the results revealed that the 2.5 MMC coated Chitosan nanoparticles had better tumor cells decline activity. From this investigation, we conclude that the drug encapsulated synthesized chitosan nanoparticles possess a high ability to be used as pH and dose responsive drug delivery system. This systematic investigation demonstrates a promising future for the intravesical installation in treatment of the superficial bladder cancer.

KEYWORDS

Chitosan Nanoparticles, Mitomycin-C, Low Releasing Drug Kinetics, Intravesical Therapy, Bladder Tumor

Share and Cite:

Kavaz, D. , Kirac, F. , Kirac, M. and Vaseashta, A. (2017) Low Releasing Mitomycin C Molecule Encapsulated with Chitosan Nanoparticles for Intravesical Installation. Journal of Biomaterials and Nanobiotechnology, 8, 203-219. doi: 10.4236/jbnb.2017.84014.

Cited by

[1]	Itraconazole and Difluorinated-Curcumin Containing Chitosan Nanoparticle Loaded Hydrogel for Amelioration of Onychomycosis
	Biomimetics, 2022

[2]	Improved oral nutraceutical-based intervention for the management of obesity: pterostilbene-loaded chitosan nanoparticles
	Kamel, RA Mehanna, HM Khalifa… - …, 2022

[3]	Fabrication of Curcumin Diethyl γ-Aminobutyrate-Loaded Chitosan-Coated Magnetic Nanocarriers for Improvement of Cytotoxicity against Breast Cancer Cells
	Polymers, 2022

[4]	5-Fluorouracil Encapsulated Chitosan-Cellulose Fiber Bionanocomposites: Synthesis, Characterization and In Vitro Analysis towards Colorectal Cancer Cells …
	Advanced …, 2021

[5]	Facile Fabrication of Polysaccharide Nanocomposites Using Ionic Gelation Method
	2021

[6]	5-Fluorouracil Encapsulated Chitosan-Cellulose Fiber Bionanocomposites: Synthesis, Characterization and In Vitro Analysis towards Colorectal Cancer Cells
	2021

[7]	Controlled release of Mitomycin C from modified cellulose based thermo-gel prevents post-operative de novo peritoneal adhesion
	2020

[8]	Synthesis of peptide-loaded chitosan nanoparticles for the treatment of sexually transmitted infections (STI's)
	2019

[9]	Nosičové systémy na bázi chitosanu pro medicínské aplikace
	2018

Journals Menu

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journals Menu

Home

About SCIRP

Service

Policies